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Psychedelic drugs produce profound changes in consciousness, but the underlying neurobiologicalmechanisms for this remain unclear.
Spontaneous and induced oscillatory activity was recorded in healthy human participants with magnetoencephalography after intrave-
nous infusion of psilocybin—prodrug of the nonselective serotonin 2A receptor agonist and classic psychedelic psilocin. Psilocybin
reduced spontaneous cortical oscillatory power from 1 to 50 Hz in posterior association cortices, and from 8 to 100 Hz in frontal
association cortices. Large decreases in oscillatory power were seen in areas of the default-mode network. Independent component
analysiswas used to identify a number of resting-state networks, and activity in thesewas similarly decreased after psilocybin. Psilocybin
had no effect on low-level visually induced and motor-induced gamma-band oscillations, suggesting that some basic elements of oscil-
latory brain activity are relatively preserved during the psychedelic experience. Dynamic causal modeling revealed that posterior cingu-
late cortex desynchronization can be explained by increased excitability of deep-layer pyramidal neurons, which are known to be rich in
5-HT2A receptors. These findings suggest that the subjective effects of psychedelics result fromadesynchronizationof ongoingoscillatory
rhythms in the cortex, likely triggered by 5-HT2A receptor-mediated excitation of deep pyramidal cells.
Introduction
Psychedelics have been used in various human cultures for thou-
sands of years. Recent studies have shown that a single dose of a
psychedelic can produce remarkable effects, such as profound
spiritual experiences and long-term changes in personality (Ma-
cLean et al., 2011). Other research suggests that psychedelics may
be useful in treating alcohol dependence (Krebs and Johansen,
2012), obsessive-compulsive disorder (Moreno et al., 2006), and
anxiety related to terminal illness (Grob et al., 2011). It has also
been proposed that psychedelics may model certain psychotic
symptoms (Vollenweider et al., 1998; Carhart-Harris et al.,
2012b). The neural mechanisms mediating all of these effects
remain largely unknown, but it is known that all psychedelics are
5-HT2A receptor agonists (Glennon et al., 1984; Vollenweider et
al., 1998).
Electroencephalographic (EEG) studies in humans have
found decreased cortical synchrony after ingestion of the psyche-
delic plant brew ayahuasca (Riba et al., 2004). Local field poten-
tial recordings in rats have demonstrated that both serotonin
(Puig et al., 2010) and the 5-HT2A receptor agonist 1-(2,5-
dimethoxy-4-iodophenyl-2-aminopropane) (DOI; Wood et al.,
2012) reduce high-frequency brain activity. However, the analy-
sis of high-frequency time-series components is difficult with
EEG recordings (Whitham et al., 2007, 2008). Magnetoencepha-
lography (MEG), the magnetic counterpart of EEG, is more ro-
bust to the tissue conduction effects present in EEG and provides
both more accurate source localization and better characteriza-
tion of high-frequency (20 Hz) activity due to the decreased
influence of muscle artifacts (Whitham et al., 2007). For these
reasons, here, for the first time, we used MEG to directly record
broadband (1–100Hz) neural activity during the human psyche-
delic state.
Recent functional magnetic resonance imaging (fMRI) stud-
ies in healthy participants found decreased blood flow and ve-
nous oxygenation in the thalamus, putamen, and association
cortices after psilocybin administration, implying decreased neu-
ral activity in these regions (Carhart-Harris et al., 2012a). How-
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ever, fMRI measures changes in neural activity indirectly via
changes in brain blood flow, which can be problematic when
studying a drug thatmight directly affect the cerebral vasculature.
Moreover, the poor temporal resolution of the blood oxygen
level-dependent (BOLD) signal of fMRI provides limited infor-
mation about the higher-frequency neural dynamics underlying
different states of consciousness. Thus, to directly assess the ef-
fects of a psychedelic on neural activity in the human brain, we
performed MEG recordings.
Fifteen healthy volunteers with prior experience with psyche-
delics received a bolus infusion of 10 ml of saline in one MEG
session and 2 mg of psilocybin in 10 ml of saline in a second
session, in a within-subjects single-blind design. Each resting-
state recording lasted 11 min. There was a 5 min preinfusion
baseline period, followed by a 60 s infusion of psilocybin, and a 5
min postinfusion period. The subjective effects of psilocybin be-
gin within seconds when administered in this way, allowing the
capture of the transition from normal waking consciousness to
the psychedelic state. Participants were instructed to relax and
keep their eyes open for the duration of the scan, and a fixation
point was presented throughout. Approximately 6 min after the
infusion, participants performed a visuomotor task designed to
elicit stimulus-induced gamma-band oscillations in the primary
visual and motor cortices. After exiting the scanner, participants
completed a 23-item questionnaire scoring specific aspects of
their psychedelic experience.
Materials andMethods
Participants
Fifteen healthy male participants (mean age, 34.5 years, SD, 2.3 years)
gave informed consent to participate in the study. The study was ap-
proved by a National Health Service research ethics committee. A phys-
ical examination, including electrocardiogram (ECG), routine blood
tests, and urine test for drugs of abuse was carried out. A psychiatric
assessment was conducted, and participants disclosed their drug-taking
histories. Exclusion criteria were as follows:21 years of age, pregnancy,
personal or immediate family history of psychiatric disorder, substance
dependence, cardiovascular disease, claustrophobia, blood or needle
phobia, or a significant adverse response to a hallucinogenic drug. All
participants had previous experience with a hallucinogenic drug but not
within 6 weeks of the study.
Drug infusion and protocol
Because psilocybin is known to cause long-term psychological changes
(Griffiths et al., 2006, 2008, 2011; MacLean et al., 2011; of unknown
biological substrate), which far outlive the drug half-life, we opted for a
fixed-order design. Participants underwent two scans on each day, one
using a placebo saline infusion, and one using psilocybin. The psilocybin
was always received second, but participants were blinded to the order of
infusion. To minimize any potential order effect (see Discussion), we
compared the postinfusion data with a preinfusion baseline. For
stimulus-induced activity, we have already demonstrated that the proto-
cols used are extremely robust to time-of-day and repeated-exposure
effects (Muthukumaraswamy et al., 2010, 2013a,b). Participants were
seated in theMEGwith their heads partly stabilized by a plastic chin rest.
In each scan session, 5 min of resting MEG was recorded, and then the
participant was infused over 60 s (2mg in 10ml of saline). The subjective
effects of psilocybin begin within seconds (Carhart-Harris et al., 2011,
2012a) of infusion, and hence we recorded 5 min of resting MEG data
immediately after infusion. At this point, participants were asked to pro-
vide a rating of their subjective “high” on a scale between 0 and 100 using
button press in the scanner. Following this, the 10min visuomotor stim-
ulation task was performed (described below). Participants provided an-
other rating after completion of this task. Participants’ pulse rate and
blood oxygenation level were continually monitored throughout the ex-
periment. After scanning, participants were asked to complete a 23-item
subjective rating scale pertaining to characteristic effects of psychedelics.
The rating scale structure was informed by the five-dimension altered
states of consciousness rating scale of Dittrich (1998), but the items were
selected based on our own previous empirical work (Carhart-Harris et
al., 2011, 2012a), and were reduced to 22 items (plus 1 control item) for
concision and to reflect subjective phenomena that are most character-
istic of the psychedelic state.
Visuomotor paradigm
Following the resting recordings, participants were presented with a vi-
sual stimulus consisting of a vertical, stationary, maximum-contrast, 3
cycles/°, square-wave grating presented on a mean luminance back-
ground. The stimulus subtended 8° both horizontally and vertically with
a small red fixation square located at the center of the stimulus, which
remained on for the entire stimulation protocol (Muthukumaraswamy
et al., 2009; Swettenham et al., 2009). The stimulus was presented on a
Mitsubishi Diamond Pro 2070 monitor controlled by the Psychophysics
Toolbox (Brainard, 1997; Pelli, 1997). The screen size was 1024  768
pixels, and the monitor frame rate was 100 Hz. The monitor was outside
the magnetically shielded room and was viewed directly from within, at
2.15 m, through a cutaway portal in the shield. The duration of each
stimulus was 1.5–2 s followed by 2 s of the fixation square only. Partici-
pants were instructed to fixate for the entire experiment and to maintain
attentionwhere instructed to abduct their index finger at the termination
of each stimulation period. This recording took10 min.
MEG acquisition and analysis
Whole-headMEG recordings weremade using a CTF 275-channel radial
gradiometer system sampled at 600 Hz (0–150 Hz bandpass filter). An
additional 29 reference channels were recorded for noise cancellation
purposes, and the primary sensors were analyzed as synthetic third-order
gradiometers (Vrba andRobinson, 2001). Three of the 275 channels were
turned off due to excessive sensor noise. At the onset of each stimulus
presentation, a transistor–transistor logic pulse was sent to the MEG
system. Participants were fitted with three electromagnetic head coils
(nasion and preauriculars), which were localized relative to the MEG
system immediately before and after the recording session. Additional
vertical and horizontal electroculograms, an ECG, and an electromyo-
gram (EMG) from the right first dorsal interosseus were also recorded
with the MEG. Additionally, finger movements of the right index finger
during the visuomotor task were recorded with an optical displacement
system (Muthukumaraswamy, 2010).
For source localization, a 3D Fast Spoiled Gradient Recalled (FSPGR)
anatomical MRI scan was obtained using a 3 T General Electric HDx
scannerwith an eight-channel receive-only head receptive-field coil from
each participant. Fast spoiled gradient echo scans were acquired in an
oblique–axial orientation, with 1 mm isotropic voxel resolution. To
achieve MRI/MEG coregistration, for source localization, the fiduciary
markers were placed at fixed distances from anatomical landmarks iden-
tifiable in participants’ anatomical MRIs (tragus, eye center). Fiduciary
locations were verified afterward using digital photographs.
MEG analysis
Preprocessing of resting data. Five minutes of data obtained immediately
before the beginning of infusion and immediately after the cessation of
infusion were extracted from the continuous recording, high-pass fil-
tered at 1 Hz, and segmented into epochs of 2 s in length. We discarded
the MEG data during infusion as it was potentially confounded, and as
participants could sometimes detect the solution entering their arm or
hear the physicianmove as they dispensed the solution (themagnetically
shielded room is nearly silent). Hence, there were 150 epochs both pre-
infusion and postinfusion for analysis. Each epoch was visually in-
spected, and those with gross artifacts (e.g., head movements, jaw
clenches) were removed from the analysis. One participant was removed
from all MEG analyses due to excessive artifacts (head movements and
jaw clenching).
Source localization of resting oscillatory changes. To localize drug-
induced changes in oscillatory power, we used the beamformer algo-
rithm synthetic aperture magnetometry (SAM; Robinson and Vrba,
1999). In addition to localizing activity, beamformers are effective in
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detecting and suppressing a number of potential artifacts, including
muscle (Carl et al., 2012), ocular (Bardouille et al., 2006), dental (Cheyne
et al., 2007), and stimulator artifacts (Litvak et al., 2010). Global covari-
ancematrices were calculated for the following six bandpass-filtered ver-
sions of the datasets: delta (1–4 Hz), theta (4–8 Hz), alpha (8–13 Hz),
beta (13–30Hz), low gamma (30–50Hz), and high gamma (50–100Hz).
These frequency bands were based on previous investigations of resting-
state MEG data (Brookes et al., 2011; Hall et al., 2013). Based on these
covariance matrices, using the beamformer algorithm (Robinson and
Vrba, 1999), a set of beamformer weights was computed for all voxels in
the brain at 4 mm isotropic voxel resolution. A multiple local-spheres
(Huang et al., 1999) volume conductor model was derived by fitting
spheres to the brain surface extracted by the FSL Brain Extraction Tool
(Smith, 2002). For SAM imaging, virtual sensors were constructed at
each beamformer voxel and Student’s t images of source power changes
computed for postinfusion versus preinfusion epochs.
Group statistical analysis was conducted using software from the FSL
software library (www.fmrib.ox.ac.uk/fsl/). Individual SAM images were
first spatially normalized onto the MNI (T1) average brain using the
FMRIB Linear Affine Registration Tool (FLIRT). This was done by first
obtaining a set of warping parameters by registering the participant’s
anatomical MRI with the average brain and then applying these param-
eters to the SAM source power maps. Statistical group analysis of the
normalized SAM images was performed on each condition and fre-
quency band image using nonparametric permutation testing (Nichols
and Holmes, 2002; Singh et al., 2003). Five thousand permutations were
calculated for each statistical test conducted with a 5 5 5mmGauss-
ian smoothing kernel applied to the variance maps. We computed a
paired t test for the placebo versus psilocybin after and before images to
reveal the drug interaction effect. t images were thresholded at p 0.05
(corrected, two-tailed). For all bands, we used the statistical omnibus to
correct for multiple comparisons, except in the 50–100 Hz band where
we used a less conservative (Chau et al., 2004) cluster-based threshold
with an initial cluster-forming threshold of 2.3 (Nichols and Holmes,
2002).
Based on the source reconstruction images, we reconstructed sources
from the posterior cingulate cortex (PCC)/precuneus using theHarvard-
Oxford Atlas. For frequency analysis of the virtual sensors, we computed
power spectral density estimates usingHanning window FFTs. Statistical
analysis of these was conducted using 2 2 repeated-measures ANOVA
using a resampling approach in the FSL randomize (5000 permutations).
Independent component analysis network analysis. For analysis of oscil-
latory networks, we used the methodology described in Brookes et al.
(2011) on the preprocessed MEG data. For each participant and fre-
quency band, beamformer weights were computed on an 8 mm grid
based on the preprocessed dataset. Beamformer time courses were then
generated at every voxel and normalized by an estimate of the projected
noise amplitude at that voxel. The Hilbert transform was applied to each
voxel time course, and the absolute value was computed to generate an
amplitude envelope of the oscillatory signals in each frequency band. The
data at each voxel was downsampled to an effective sampling rate of 1Hz,
transformed to standard (MNI) space using FLIRT in FSL, and data from
all subjects were concatenated in the time dimension across subjects.
Temporal independent component analysis (ICA) was applied to the
concatenated datasets (separately for all six frequency bands) using the
fast ICA (research.ics.tkk.fi/ica/fastica) algorithm. Prewhitening was ap-
plied to reduce the dimensionality of the source space Hilbert envelope
signals to 20 principal components before ICA (Hyva¨rinen and Oja,
2000; Brookes et al., 2011; Hall et al., 2013). Fifteen independent com-
ponents were derived for each frequency band. To reduce the number of
independent components subsequently analyzed, the following strategy
was applied: each component was classified as follows: (1) an artifact due
to either physiological or beamformer errors (deep brainstem sources);
(2) a unimodal component; or (3) a network. Since we had already local-
ized the changes in source power, we specifically focused on components
in category 3. In total, 11 such components were identified. For these
components, we computed the SD of the component time course for
each subject and condition. Differences in the SD of the independent
component time course between placebo and psilocybin were assessed
using 2  2 repeated-measures ANOVAs in those where p  0.01 was
reported.
Dynamic causal modeling. The purpose of the dynamic causal model-
ing (DCM)—in the context in which we have used it here—is to link the
spectral changes we observed in the PCC/precuneus with underlying
synaptic changes that occurred with the drug. We focused on recon-
structed source activity from the PCC/precuneus as convergent evidence
from fMRI, arterial spin labeling (ASL), and positron emission tomog-
raphy (PET), and nowMEG, suggests that the posterior parietal lobe is a
key area involved in the human psychedelic experience (Erritzoe et al.,
2009; Carhart-Harris et al., 2012a). To do this, we used dynamic causal
modeling for steady-state responses previously described in a number of
articles (Moran et al., 2007, 2009, 2011).
The canonical microcircuit (neural-mass) model we used here was
composed of four subpopulations consisting of spiny stellate cells, inhib-
itory interneurons, deep pyramidal cells, and superficial pyramidal cells.
The connectivity of each neural subpopulation is summarized in Figure
1. The behavior of each subpopulation is modeled with pairs of first-
order differential equations of the following form (Moran et al., 2009):
x˙v  xI, (1)
x˙I  U  2xI  
2xv.
The column vectors xv and xI correspond to the mean voltages and cur-
rents, where each element corresponds to the hidden state of the subpop-
ulation. These differential equations implement a convolution of a
subpopulation’s presynaptic input (U) to produce a postsynaptic re-
sponse (Fig. 1), where the rate constants () represent an inverse of a
lumped parameter that accounts for all dendritic and membrane time
delays. Delays between the layers are accounted for through a Jacobian
expansion (Kiebel et al., 2007) and have a prior value of 1 ms. The
presynaptic input to the subpopulations comprises an endogenous com-
ponent, E, which is a mixture of white and pink noise perturbations
(these enter only the stellate cells; Table 1, see u and u in Parameters),
and a scaled input of ensemble firing from each prescribed presynaptic
population (the signs of these inputs are shown in Fig. 1 and implement
effective excitability or gain increases and decreases). Firing rates from
presynaptic subpopulations are prescribed through a sigmoidal trans-
form (slope 2/3) dependent on their membrane depolarization (Mo-
ran et al., 2009).
U  S xvpresynaptic  E. (2)
The output of the model is a mixture of the depolarization of each sub-
population. Since pyramidal dendrites are oriented tangentially to the
cortical surface in a more “open field” configuration (Murakami and
Okada, 2006), the contribution of each subpopulation is weighted and
optimized during inversion. This is augmented with a parameterized
channel noise component and amplifier gain to comprise the full ob-
server function. Here we used prior weights of 20% for deep pyramidal
cells (x_V_DP), 80%for superficial pyramidal cells (x_V_SP), and 20% for
the stellates (x_V_SC).
The generative model created above was then inverted (fitted to the
data) to obtain the posterior densities of the parameters. In DCM, a
variational Bayesian scheme (variational Laplace) is used to approximate
the posterior density over parameters by maximizing the negative free
energy, a bound on the log-model evidence (Friston et al. (2007)). The
parameters operate as scaling values on prior expectations. The full list of
parameters and the sufficient statistics of their priors is given in Table 1,
and the fullmassmodelwith equations is represented in Figure 1.Most of
the intrinsic connectivity () parameters that connect the different neu-
ronalmasses would represent glutamatergic or GABAergic synapses. Psi-
locybin acting on serotonin receptors would modulate the excitability of
neuronal masses; that is, it would modulate the gain of the populations
that contain these receptor types. That is, psilocybin has a neuromodulatory
influence (i.e., rather than being directly GABAergic or glutamatergic).
Therefore,we specificallymodeledprespectral versuspostspectral changes as
a set of parameters (1 . . . 4). These four parameters effectively modeled
drug-induced modulations of the gain of each population in the neuronal
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mass (Table 1). Parameters 1-modeled changes in 1 (stellate cell gain),
2-modeledchanges in7 superficialpyramidal cell gain,3-modeled inhib-
itory interneurongain in4, and4-modeleddeeppyramidal cell gain in10.
Having obtained these14 parameter estimates, we then performed paired
t tests comparing them between placebo and psilocybin infusion over
subjects.
Visual and motor responses. Analysis of motor cortical responses to the
offset of the visual stimulus was conducted in a very similar fashion to those
we (Muthukumaraswamy, 2010, 2011; Hamandi et al., 2011; Muthukuma-
raswamyet al., 2013b) andothers havepreviously reported (Jurkiewicz et al.,
2006; Cheyne et al., 2008; Gaetz et al., 2010, 2011). From the continuous
MEG recordings, EMG onsets were marked using an automated algorithm
that marked increases in the rectified EMG signal by 3 SDs above the noise
floor (Cheyneet al., 2008), subject to theconstraint that theyoccurredwithin
1 s of the tone pip. Data were epoched from1.5 s before to 3 s after the EMG
markers. Each trial was then visually inspected and discarded for any of the
following reasons: (1) excessiveMEG signal artifacts (e.g., headmovements/
jaw clenches); (2) irregular movement displacements (e.g., double move-
ments); or (3) irregular EMGactivity. Analysis of visual cortical responses to
the onset of the grating stimulus was conducted in a very similar fashion to
those we (Muthukumaraswamy et al., 2009, 2010, 2013a; Gaetz et al., 2012;
MuthukumaraswamyandSingh, 2013; Perry et al., 2013; Saxena et al., 2013)
and others (Adjamian et al., 2004; Brookes et al., 2005; Hall et al., 2005;
Hadjipapas et al., 2007; Schwarzkopf et al., 2012) have previously reported.
Data were first epoched from1.5 to 1.5 s around stimulus onset, and
each trial was visually inspected for data quality. Epochs with gross
artifacts, such as head movements and muscle clenching, were ex-
cluded from further analysis.
For source localization of the data, we used SAM (Robinson and Vrba,
1999) with a set of beamformer weights (4 mm resolution) calculated
from global covariance matrices in the gamma band (60–90 Hz for mo-
tor, 35–80Hz for visual). For SAM image reconstruction, virtual sensors
were constructed for each beamformer voxel and Student’s t test images
of source power changes were computed (Table 2). Using parameters
fromCheyne et al. (2008),Muthukumaraswamy (2010), andHamandi et
al. (2011) for motor gamma localization, we used a baseline period of
1.3 to 1 s, and an active period of 0–0.3 s, while for visual cortex
localization we used a baseline period of1.5 to 0 s, and an active period
of 0–1.5 s. After generating the source reconstruction images, the voxels
with the strongest change in visual and motor cortices were located, and
virtual sensors were constructed at these peak locations. To reveal the
time–frequency response at a virtual sensor location, the virtual sensor
was repeatedly bandpass filtered at 0.5 Hz frequency step intervals using
an 8-Hz-wide third-order Butterworth filter from 1 to 150 Hz (Le Van
Quyen et al., 2001; Muthukumaraswamy, 2010; Saxena et al., 2013). At
each frequency step, the Hilbert transform was used to obtain the time-
varying amplitude envelope, and the envelopeswere then averaged across
trials. In a first iteration of the analysis, we computed time–frequency
spectra as the percentage change from baseline values. In a second itera-
tion, unbaselined maps were calculated to check for differences in the
prestimulus baseline spectra (Muthukumaraswamy et al., 2013b; Saxena
et al., 2013). From the baseline time–frequency spectra, amplitude enve-
lopes were calculated for beta (15–30 Hz) and gamma (60–90 Hz;
Muthukumaraswamy et al., 2013b) bands for the motor cortex, and for
alpha (8–13 Hz) and gamma (35–80 Hz) bands in the visual cortex. We
searched for differences in the frequency band-limited envelopes with
paired t tests at each sample point using a resampling approach (Nichols
and Holmes, 2002) in FSL Randomize (5000 permutations). Permuted t
statistics were corrected for multiple comparisons using cluster-based
techniques (Maris and Oostenveld, 2007) with an initial cluster-forming
Figure 1. Summary of the neural mass model used in the dynamic causal modeling.
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threshold of t 2.3. This approach allowed us to examine the temporal
profile of oscillatory spectral modulations and, in the case of alpha activ-
ity, to study changes after 300 ms that were not confounded by the
evoked response.
Results
Subjective effects
All participants reported marked changes in their normal con-
scious experience after psilocybin infusion. The most common
effects included altered visual, spatial, and temporal perception;
loosened associations; and vivified imagination. However, more
profound effects such as depersonalization or “ego disintegra-
tion”were also scored highly by some participants. Expressed as a
percentage, with 100% signaling “extremely intense effects,” par-
ticipants rated the subjective strength of their experience at
78.2% (SE, 5.5%) 5min after infusion of psilocybin, decreasing to
65.4% (SE, 4.7%) after 15 min; placebo had negligible effects
(both time points, 0.7%; SE, 2.5%). Items rated 15min postscan-
ning are shown in Figure 2.
Spectral analysis and source localization:
spontaneous activity
To localize corresponding spectral changes in cortical activity, we
used the beamformer source localization technique SAM. Figure
3 displays the contrast of psilocybin after versus before infusion
compared with placebo after versus before infusion. Results re-
vealed decreased oscillatory power across a broad frequency
range after psilocybin infusion, mainly localized to association
cortices—with marked decreases in areas of the default-mode
network (DMN; Raichle et al., 2001) such as the PCC. In poste-
rior areas, the decreases were observed in the delta (1–4 Hz),
theta (48Hz), alpha (8–13Hz), beta (13–30Hz), and low gamma
(30–50 Hz) frequency bands. In bilateral prefrontal cortices, the
decreased power (“desynchronization”) ranged from alpha
(8–13 Hz) to high gamma (50–100 Hz). The result of simple
Table 1. DCM parameter priors including the observationmodel, neuronal model,
and experimental effects
Parameters
Prior
InterpretationMean ()
Variance
(	)
Observation model
u 0 1/16 Exogenous white input
s 0 1/16 Channel white noise
u 0 1/16 Exogenous pink input
s 0 1/16 Channel pink noise
	 1 1 Lead-field gain

Deep, super, stellate 
0.2, 0.8, 0.2 
1/16 
Subpopulation contributions
Neuronal sources
1/1 2 ms 1/16 Time constant (s.s.)
1/2 2 ms 1/16 Time constant (s.p.)
1/3 16 ms 1/16 Time constant (i.i.)
1/4 28 ms 1/16 Time constant (d.p.)
1 4 1/16 Intrinsic connection (s.s. tos.s.)
2 4 1/16 Intrinsic connection (s.p. tos.s.)
3 4 1/16 Intrinsic connection (i.i. tos.s.)
4 4 1/16 Intrinsic connection (i.i. toi.i.)
5 4 1/16 Intrinsic connection (s.s. toi.i.)
6 2 1/16 Intrinsic connection (d.p. toi.i.)
7 4 1/16 Intrinsic connection (s.p. tos.p.)
8 4 1/16 Intrinsic connection (s.s. tos.p.)
9 2 1/16 Intrinsic connection (i.i. tod.p.)
10 1 1/16 Intrinsic connection (d.p. tod.p.)
D 1 ms 1/16 Laminar delay
Experimental design
 1 0 1/8 Modulation of1
 2 0 1/8 Modulation of7
 3 0 1/8 Modulation of4
 4 0 1/8 Modulation of10
s.s., Spiny stellate; s.p., superficial pyramidal; i.i., inhibitory interneuron; d.p., deep pyramidal.
Table 2. Local maxima of source power changes (Talairach coordinates)
corresponding to the images in Figure 1
Talairach coordinates
tx y z
Delta
Precuneus (R) 25 63 31 8.14
Posterior cingulate gyrus (L) 23 45 37 7.55
Insula (L) 55 33 19 6.88
Precentral gyrus (L) 39 19 35 6.38
Postcentral gyrus (R) 55 11 53 5.08
Anterior cingulate gyrus (L) 19 25 33 4.74
Postcentral gyrus (R) 51 17 25 4.60
Superior frontal gyrus (L) 15 11 53 4.50
Theta
Superior parietal lobule (R) 29 57 61 6.24
Postcentral gyrus (L) 27 37 51 5.42
Superior temporal gyrus (L) 49 55 15 5.35
Superior parietal lobule (L) 15 67 65 5.11
Precuneus (L) 5 47 53 4.98
Paracentral lobule (L) 5 41 77 4.83
Precentral gyrus (R) 39 15 69 4.30
Supramarginal gyrus (R) 53 47 31 4.19
Alpha
Superior parietal lobule (L) 13 53 61 8.95
Precuneus (L) 7 61 33 8.94
Supramarginal gyrus (R) 59 43 29 8.65
Transverse temporal gyrus (L) 55 19 11 8.11
Superior temporal gyrus (R) 63 27 7 7.18
Insula (R) 33 11 9 7.16
Supramarginal gyrus (L) 51 51 25 6.68
Anterior cingulate gyrus (R) 5 35 11 5.48
Inferior frontal gyrus (L) 55 21 21 5.33
Middle frontal gyrus (L) 55 5 47 5.28
Cingulate gyrus (L) 1 3 31 5.15
Middle frontal gyrus (L) 21 1 45 5.07
Medial frontal gyrus (L) 5 3 51 5.06
Middle frontal gyrus (R) 29 9 57 4.70
Beta
Precuneus (R) 25 53 33 9.15
Insula (L) 43 19 15 7.73
Superior temporal gyrus (L) 35 51 17 7.71
Medial frontal gyrus (L) 21 27 23 6.87
Superior frontal gyrus (R) 19 65 5 6.69
Superior Frontal gyrus (R) 5 59 27 6.50
Superior parietal lobule (L) 21 69 63 6.31
Inferior frontal gyrus (L) 57 13 35 6.26
Postcentral gyrus (L) 59 33 53 5.74
Superior frontal gyrus (R) 17 17 65 4.83
Low gamma
Precentral gyrus (R) 37 25 71 5.28
Superior parietal lobule (L) 19 61 65 5.17
Precentral gyrus (L) 35 7 69 5.04
Middle frontal gyrus (L) 47 33 31 4.91
Superior frontal gyrus (L) 43 15 55 4.91
Postcentral gyrus (R) 15 59 69 4.72
Middle frontal gyrus (L) 23 15 57 4.71
Middle frontal gyrus (R) 43 23 49 4.55
Superior parietal lobule (R) 41 59 57 4.29
Precentral gyrus (L) 55 19 37 4.28
High gamma
Middle frontal gyrus (L) 43 15 57 3.22
Middle frontal gyrus (R) 31 23 59 3.18
Superior frontal gyrus (R) 23 1 71 2.89
Precentral gyrus (L) 63 15 41 2.84
L, Left; R, right.
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contrasts between after and before psilocybin infusion showed
very similar spatial localizations and direction of effect compare
with those of the interaction contrast in Figure 3 (i.e., decreased
power). No increases in oscillatory power were observed in any
region. As such, the interaction effects in Figure 3 can be inter-
preted as a decrease of power following administration of psilo-
cybin. A comparison of head position from the beginning to the
end of the resting MEG recordings showed no significant differ-
ence in movement between psilocybin and placebo sessions (t
0.63, p 0.53).
Figure 2. Ratings of psychometric scale items performed within 15 min of participants exiting the scanner after both sessions. Items were completed using a visual analog scale format, with a
bottom anchor of “no, not more than usually” and a top anchor of “yes, muchmore than usually” for every item, with the exception of “I felt entirely normal,” which had bottom and top anchors of
“No, I experienced a different state altogether” and “Yes, I felt just as I normally do,” respectively. Shown are the mean ratings for 15 participants plus the positive SEMs. All items marked with an
asterisk were scored significantly higher after psilocybin than placebo infusion at a Bonferroni-corrected significance level of p 0.0022 (0.5/23 items).
Figure 3. Statistical parametric maps showing the locations of significant ( p 0.05, corrected) changes in source oscillatory power. Contrasts of spectral power represent the difference of
psilocybin after andbefore infusion versus placebo after andbefore infusion. All significant changes are decreases in spectral power after psilocybin infusion in the six frequency bands that span from
1 to 100 Hz. L, Left; R, right.
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Resting-state MEG networks
Techniques have recently been developed to identify spatiotem-
porally coherent brain networks inMEG data using independent
component analysis (Brookes et al., 2011). Applying this to our
resting-state data, we recovered 11 functional brain networks, 7
of which showed post-psilocybin infusion decreases in oscillatory
power in the frequency bands fromwhich they were derived (p
0.01, uncorrected; Fig. 4). A further four networkswere identified
that did not pass the significance criterion. These networks were
a bilateral parietal network in the delta band (p 0.065), a bilat-
eral extrastriate cortex network in the alpha band (p 0.061), a
bilateral frontal cortex network in the low gamma band (p 
0.013), and a bilateral extrastriate cortex network in the high
gamma band (p 0.057). Despite not reaching significance, ac-
tivity in these four networks was consistently decreased under the
effects of psilocybin.
Dynamic causal modeling
Recently, mathematical modeling techniques have been devel-
oped to test hypotheses about the underlying cell populations
responsible for steady-state changes in spectral power recorded
with EEG and MEG, termed DCM for steady-state responses
(Moran et al., 2009). Thus, to identify the most likely synaptic
mechanism underlying the psilocybin-induced desynchroniza-
tion, we constructed amodel based on the canonicalmicrocircuit
thought to recapitulate the intrinsic circuitry of individual corti-
cal regions (Bastos et al., 2012). Thismodel encompasses four cell
types and their respective connections (Fig. 5b). We used the
beamformer to estimate spectral activity in the PCC, which was
significantly decreased in the alpha band after psilocybin infusion
(Fig. 5a). We set up a model where drug effects could be
accounted for by differential gain (or excitability) of each of
the four cell types ( parameters; Fig. 5b). Paired t tests using a
Bonferroni-adjusted significance level of p 0.0125 (0.05/4 pa-
rameters) showed a psilocybin-dependent increase in the excit-
ability of deep-layer pyramidal cells (Fig. 5c). These modeling
results in humans are consistent with the results of the animal
studies that directly recorded 5-HT2A receptor-mediated in-
creases in EPSPs in layer 5 pyramidal cells (Andrade, 2011).
Moreover, excitation of deep-layer pyramidal cells is consistent
with decreased brain activity (Carhart-Harris et al., 2012a) and
oscillatory power because the net effect of feedback connections
is thought to be inhibitory (Bastos et al., 2012). Individual data
and model fits for each participant are presented in Figure 6.
Visually induced andmotor-induced gamma oscillations
Psilocybin had a profound effect on participants’ subjective state,
as reflected in the marked changes in spontaneous brain activity.
When asked to perform a simple visuomotor task, participants
performed reasonably well, being marginally slower (t  2.56,
p 0.023) after psilocybin (295ms; SE, 15ms) than placebo (260
ms; SE, 22 ms) infusion. Analyses of EMG onset time-locked
spectral responses are presented in Figure 7. Time–frequency re-
sponses (Fig. 7b) show the typical component morphology seen
during simple movement tasks. This morphology includes a
short-lasting burst of gamma-band activity accompanied by a
desynchronization, and later rebound of the beta rhythm (Jurk-
iewicz et al., 2006; Cheyne et al., 2008). No significant differences
were seen between placebo and psilocybin for either the gamma
(60–90 Hz) or beta (15–30 Hz) band. For the motor cortex
Figure 4. The estimated spatial distribution of seven resting-state networks that were significantly modulated ( p 0.01) by psilocybin. Network structures are superimposed onto the MNI
template brain. These independent components were thresholded at 0.2, and the frequency band used to derive eachmap is indicated by the relevant Greek letter. The right-hand graphs show the
SD of the temporal expression of each independent component for both the placebo and psilocybin conditions. This can be interpreted as ameasure of activity in the relevant frequency band for the
relevant network. The p value reflects the interaction term in a 2 2 repeated-measures ANOVA. Pre, Before; Post, after.
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source locations, we repeated the time–frequency analysis with
no baseline correction (raw source amplitude estimates) applied
to examine the baseline spectra in the frequency windows of in-
terest for each task. For the motor cortex virtual sensors, no sig-
nificant differenceswere seen in the prestimulus baseline in either
the gamma (t  0.60, p  0.56) or beta (t  1.69, p  0.11)
frequency bands.
Analyses of visual cortical responses time locked to stimulus
onset are presented in Figure 8. The time–frequency response
plots show the typical componentmorphology seen during visual
stimulation with a grating patch. This morphology includes a
short-lasting burst of broadband gamma-band activity accompa-
nied by a long-duration gamma response, together with alpha
desynchronization. No significant differences were seen in either
the gamma (35–80 Hz) or alpha (8–13 Hz) band. For the virtual
sensors from the visual cortex, no difference in baseline gamma-
band activity was seen (t0.23, p 0.82). There were baseline
alpha power differences (t 4.02, p 0.0015). This is consistent
with the resting-state analysis andmight account for the tendency
for the slight (nonsignificant) reduction in alpha desynchroniza-
tion seen during visual stimulation. Together, the analyses in
Figures 7 and 8 suggest that some low-level induced elements of
oscillatory brain activity are relatively preserved during the psy-
chedelic experience. A comparison of head position from the
beginning to the end of the task-relatedMEG recordings showed
no significant difference in movement between psilocybin and
placebo sessions (t 1.23, p 0.23).
Psychometric correlations
We conducted exploratory correlations between resting post-
psilocybin infusion changes (decreases) in alpha power extracted
from a PCC mask for each participant versus the visual analog
scale-style items rated after the experience (Fig. 1). Analyses were
restricted to the alpha frequency band to minimize multiple test-
ing and because the PCC alpha-power decreases were especially
marked (Fig. 3). Therewere strong ceiling and floor effects for the
highest and lowest rated items in the 23-item rating scale (Fig. 1),
thus making meaningful correlations with these items unlikely.
However, scores for other items were more broadly distributed.
Using a Bonferroni-adjusted significance level of p  0.0022
(0.05/23 items), two items showed positive significant correlations
with PCC alpha-power decreases. These were, “I experienced a dis-
integration of my ‘self’ or ‘ego’” (R2 0.66, p 0.00016) and “the
experience had a supernatural quality” (R2  0.53, p  0.00018).
Positive correlations were also found between deep-layer pyramidal
cell excitation and the magnitude of the decreases in PCC alpha
power (R2 0.42, p 0.0056) and ratings of ego disintegration (R2
 0.42, p 0.005). The psychometric correlations presented in this
section will require subsequent replication given their exploratory
nature.
Discussion
The present study examined the neural effects of a classic psyche-
delic drug using MEG. We observed a broadband desynchroni-
zation of cortical oscillatory rhythms after psilocybin infusion
Figure 5. a, Power spectra for reconstructed source data from the PCC. Data are presented for both psilocybin (Psilo) and placebo (Pla) sessions both before (Pre) and after infusion (Post). The
black bars represent areas where 2 2 repeated-measures ANOVA revealed an interaction effect in the frequency spectra ( p 0.05, corrected). b, Schematic representation of the neural mass
model (the canonical cortical microcircuit) used to predict spectral activity. Themodel consists of four cell types with 10 connectivity parameters (110). Four parameters (1, 2, 3, 4) encoding gain
were allowed to vary between presessions and postsessions. These four parameters allow the gain of the four cell types to differ between Pre and Post. Data fittedwere the source-modeled spectral
response of the PCC. c, The parameter estimates for the four cell types for both psilocybin and placebo. The only parameter that was significantly altered (placebo versus psilocybin) was the4
parameter (t 3.23, p 0.0065), using a paired t test over subjects. Note: the Bonferonni-adjusted significance level of p 0.0125 (0.05/4) for these tests. The direction of effect indicated that
the obtained spectral responses were best modeled by increased excitability of the deep pyramidal cell population. All individual data and model fits can be found in Figure 6. The results for all
parameterswere as follows:1 (t1.86, p 0.085);2 (t2.31, p 0.03);3 (t1.11, p 0.028); and4 (t3.23, p 0.0065). Hence, only4 survivedmultiple-comparison
correction.
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and decreased brain network integrity. The results are consistent
with those of previous EEG (Riba et al., 2004) and fMRI studies
(Carhart-Harris et al., 2012a) in humans and electrophysiological
recordings in animals (Wood et al., 2012), and they significantly
extend our understanding of the mechanisms by which psyche-
delics alter oscillatory brain activity. By exploring the neuronal
source of the decreases in oscillatory power with dynamic causal
modeling, we present a model of the mechanism of action of
psychedelics in the PCC. This begins at the cellular level with
excitation of layer 5 pyramidal neurons, and extends to the mac-
roscopic level with cortical desynchronization and decreased
brain network integrity. We postulate that this excitation occurs
via stimulation of 5-HT2A receptors, which are densely expressed
there (Erritzoe et al., 2009).
Previous pharmacological EEG and MEG studies have found
increases and decreases in oscillatory power in different fre-
quency bands post-drug infusion (Fink, 1969, 2010). That the
decreases here occurred in all of the frequency bands implies a
general collapse of the normal rhythmic structure of cortical
activity. This supports the claim that psychedelics decrease, or,
more accurately, disorganize, spontaneous brain activity
(Carhart-Harris et al., 2012a). Moreover, the selective localiza-
tion of the decreases to association cortices is consistent with
previous fMRI work (Carhart-Harris et al., 2012a) and suggests
that the reduced blood flow reported thereinmay relate to desyn-
chronized neural activity. Indeed, the MEG source localization
results we find here are highly consistent with previous fMRI
results using the same pharmacological intervention (Carhart-
Harris et al., 2012a). Some of the key areas of overlap include the
PCC, precuneus, superior and middle frontal gyri, anterior cin-
gulate gyri, and supramarginal and precentral gyri. These mostly
represent hub areas of association cortex rather than primary
sensory cortex. The PCC showed especially marked effects in
both studies, and these correlated with the drug’s subjective ef-
fects (e.g., note the highly significant correlation between PCC
alpha decreases and ratings of ego disturbance observed here). It
is significant also that the spatial location of the effects observed
with fMRI and MEG are consistent with the known distribution
of 5-HT2A receptors. Explicitly, in a PET study of 5-HT2A recep-
tor binding using 18F-altanserin in 136 participants, association
cortices had the highest binding potentials, and the PCC was
highest of all (Erritzoe et al., 2009). The posterior association
cortices showed desynchonization in a lower frequency range
(1–50 Hz), whereas frontal association cortices showed higher
frequency changes (8–100 Hz). These frequency differences may
reflect the different resting rhythms that these areas spontane-
ously generate (Buzsaki, 2006). It is important not to overinter-
pret the specificity of MEG source localization data, as these data
have inferior spatial resolution compared with both fMRI and
PET. We did note, in some single-participant data, strong high-
frequency desynchronizations in posterior association areas.
However, these were quite inconsistent across both individuals
Figure 6. Single-participant [participant 1 (P1) to P14] DCM model fits for source-level power spectra for prerecordings and postrecordings following placebo and psilocybin infusion for
reconstructedPCC activity.Model-estimated spectra for Pre are in red andPost are in blue, and are overlaid on thedata in black. DCMmodelswere fitted from the range1–100Hzbut are plottedhere
only up to 50 Hz for better visualization of alpha peaks.
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and cortical locations, and did not survive
at the group-level analysis. Further inves-
tigations will be needed to explain these
individual differences in observed neural
responses to psychedelic drugs.
A number of previous studies have in-
vestigated the relationship between blood
flow metrics and oscillatory activity. These
have generally foundan inverse relationship
between BOLD activity and alpha/beta
rhythms (Goldman et al., 2002; Singh et al.,
2002; Laufs et al., 2003; Scheeringa et al.,
2011), while a positive relationship is found
between gamma-band activity and BOLD
activity (Logothetis et al., 2001; Scheeringa
et al., 2011). With psilocybin, however, we
observe a decrease in BOLD activity and a
general decrease in oscillatory activity dur-
ing resting-state conditions. The hypercap-
nic challenge delivered byCarhart-Harris et
al. (2012a) suggests that theBOLDdecreases
seen in that study were not a confound of
psilocybin working directly on the cerebral
vasculature. Consistent with our human
data, administration of the relatively selec-
tive 5-HT2A receptor agonistDOI in rats re-
sulted in dose-dependent decreases in
broadband (including high-frequencies)
oscillatory power and multiunit activity in
theorbitofrontal andanterior cingulate cor-
tices (Wood et al., 2012). This suggests a
generalized reduction in neural activity (at
least in terms of oscillations and hemody-
namics) with 5-HT2A receptor activation
and a decoupling of the usual relationship
between BOLD and neural oscillations.
In the present study, some of the larg-
est decreases in oscillatory power were
found in areas of the DMN (Fig. 3) con-
sistent with recent fMRI studies revealing
decreased blood flow in these regions after
psilocybin infusion (Carhart-Harris et al.,
2012a). TheDMN consumesmore energy
(Raichle and Snyder, 2007), receivesmore
perfusion (Zou et al., 2009), and is more
widely connected (Hagmann et al., 2008)
than other cortical regions. It undergoes
significant ontogenetic development (Su-
pekar et al., 2010) and underwent signifi-
cant evolutionary expansion (Van Essen
and Dierker, 2007), and its connectivity
has been found to relate to personality
(Adelstein et al., 2011) and psychopathol-
ogy (Whitfield-Gabrieli and Ford, 2012).
Several recent intracranial studies (Jerbi et
al., 2010; Ossando´n et al., 2011) have dem-
onstrated that broadband, high-frequency,
task-related suppression ofDMNareas cor-
relates with improved task performance. In
these studies (Ossando´n et al., 2011), during
task performance, activity in task-positive
networks emerges, whereas in the psyche-
delic state studied here a pharmacologically
Figure 8. a, Grand-averaged source activity for visual gamma (35–80 Hz) activity ( p 0.05, corrected) following adminis-
tration of either placebo or psilocybin. For each, the grand-averaged peak source location for each was located in pericalcarine
cortex. b, Grand-averaged time–frequency spectrograms showing source-level oscillatory amplitude changes following visual
stimulation with a grating patch (stimulus onset at time 0) following administration of either placebo or psilocybin. Spectro-
grams are displayed as the percentage change from the prestimulus baseline andwere computed for frequencies up to 150Hz, but
are truncated here to 100Hz for visualization purposes. c, Envelopes of oscillatory amplitude for the gamma (35–80Hz) and alpha
(8–13 Hz) bands, respectively. Although there was a tendency for slightly reduced alpha desynchronization with psilocybin, this
was not statistically significant.
Figure7. a, Grand-averaged sourceactivity formovement-relatedgamma(60–90Hz) activity ( p0.05, corrected) following
administration of either placebo or psilocybin. The grand-averaged peak source location for eachwas located in Brodmann area 4.
b, Grand-averaged time–frequency spectrograms showing source-level oscillatory amplitude changes following index finger
movement (movement onset at time 0). Spectrograms are displayed as the percentage change from the prestimulus baseline
and were computed for frequencies up to 150 Hz, but are truncated here to 100 Hz for visualization purposes. c, Envelopes of
oscillatory amplitude for the gamma (60–90 Hz) and beta (15–30 Hz) bands, respectively. No significant differences were seen
between placebo and psilocybin for these envelopes.
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driven suppression of all observed networks was seen, suggesting a
general disorganization of network-level brain activity during rest-
ing conditions.
Psilocin is a mixed serotonin receptor agonist (Halberstadt
and Geyer, 2011). However, the potency of psychedelics corre-
lates positively with their affinity for the 5-HT2A receptor (Glen-
non et al., 1984), and pretreatment with the 5-HT2A receptor
antagonist ketanserin blocks the hallucinogenic effects of psilo-
cybin in humans (Vollenweider et al., 1998). 5-HT2A receptors
are densely expressed in cortical regions (Erritzoe et al., 2009),
particularly in cortical layer 5 (Weber and Andrade, 2010). The
presentmodeling results, indicating increased excitation of deep-
layer pyramidal cells, are entirely consistent with previous re-
search. Stimulation of the 5-HT2A receptor has been shown to
enhance spontaneous EPSPs/EPSCs in neocortical layer 5 pyra-
midal cells by reducing outward potassium currents (Aghajanian
and Marek, 1997; Lambe et al., 2000) and to cause increased
glutamatergic recurrent activity in layer 5 of the cortex (Be´ïque et
al., 2007). It is noteworthy that, while the decreases in spectral
power seen here were broad, decreases in the alpha frequency
were especially marked—particularly in the PCC where 5-HT2A
receptors are densely expressed (Erritzoe et al., 2009). Layer 5
pyramidal cells fire with an intrinsic alpha rhythm (Silva et al.,
1991; Sun andDan, 2009) and spontaneous alpha oscillations are
closely linked to perceptual processing, including processing of
space and time (Lorincz et al., 2009; Klimesch, 2012). Thus, the
marked decreases in alpha power observed here with psilocybin
were likely due to interferencewith the intrinsic alpha oscillations
of deep-layer pyramidal neurons via stimulation of 5-HT2A re-
ceptors, although we observed marked changes in spontaneous
brain activity after psilocybin, but no effects on low-level induced
gamma-band responses.
There are some limitations to the present work. Participants
all had previous experience with psychedelic drugs. This was to
minimize the risk of adverse responses by excluding volunteers
who had a history of reacting negatively to psychedelics. How-
ever, that we used experienced participants limits the generaliz-
ability of the present results to psychedelic-naive individuals.
Also, we used a fixed-order scanning protocol to avoid contam-
inating the placebo condition with subacute drug effects. A
balanced-order design with a prolonged period between scans
may be an alternative experimental design, although it would be
difficult to perform in practice. However, we suggest that any
potential order effects would likely be subtle relative to the
marked neuronal and subjective effects of psilocybin. Reinforc-
ing this view, in our previous fMRI work with psilocybin, similar
results were observed with balanced (BOLD) and fixed (ASL)
order scanning (Carhart-Harris et al., 2012a). This was also a
single-blind design. However, in experiments such as this, com-
paring the acute effects of potent psychoactive drugswith those of
a (necessarily) inert placebo, participants quickly become “un-
blinded” to the experimentalmanipulation, thus diminishing the
value of blinding. Finally, it was necessary to remove periods of
MEGdata that were contaminated by large-muscle artifacts/head
movements in the preprocessing stage. If these artifacts were cor-
related with particular aspects of the psychedelic state, then this
(necessary) preprocessing step precluded their detection.
Previous theoretical accounts of positive psychotic symptoms
suggest that delusional thinking represents a failure of neural
mechanisms to accurately encode predictions and prediction er-
ror or “surprise” (Corlett et al., 2010). In one prediction-coding
model of global brain function based on the free-energy principle
(Friston, 2010), activity in deep-layer projection neurons en-
codes top-down inferences about the world. Speculatively, if
deep-layer pyramidal cells were to become hyperexcitable during
the psychedelic state, information processing would be biased in
the direction of inference—such that implicit models of the
world become spontaneously manifest—intruding into con-
sciousness without prior invitation from sensory data. This could
explain many of the subjective effects of psychedelics.
Finally, the therapeutic potential of psychedelics is currently
attracting much interest (Grob et al., 2011; Krebs and Johansen,
2012). Frontoparietal connectivity has been found to correlate
with rumination in depression (Berman et al., 2011), and defi-
cient 5-HT2A receptor stimulation have been found to be associ-
ated with trait neuroticism (Frokjaer et al., 2008) and pessimism
(Meyer et al., 2003).Herewe found decreased frontoparietal con-
nectivity after psilocybin infusion, consistent with previous fMRI
findings (Carhart-Harris et al., 2012a). Thus, the ability of sero-
tonergic psychedelics to disrupt pathological patterns of brain
activity via stimulation of 5-HT2A receptors may underlie their
therapeutic potential in psychiatric settings (Grob et al., 2011;
Krebs and Johansen, 2012), and breakdown of brain networks
may be a fundamental feature of the psychedelic state.
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